Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas Huleux
Observed names:
HULEUX, Thomas,
Huleux, Thomas,
Thomas HULEUX
Institution:
Centre Hospitalier de Tourcoing
Observed institutions:
Centre Hospitalier Universitaire de Reims,
Centre Hospitalier de Tourcoing
OpenAlex ID:
A5112613613
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients
2018
·
Clotilde Allavena
, Matthieu Hanf
, et al.
·
PLoS ONE
·
89
PDF
A highly virulent variant of HIV-1 circulating in the Netherlands
2022
·
Chris Wymant
, Daniela Bezemer
, et al.
·
Science
·
82
PDF
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
2019
·
Guillemette Antoni
, Cécile Tremblay
, et al.
·
The Lancet HIV
·
82
PDF
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial
2022
·
Roland Landman
, Pierre de Truchis
, et al.
·
The Lancet HIV
·
69
PDF
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV
2018
·
Pierre Pradat
, Thomas Huleux
, et al.
·
AIDS
·
69
Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization
2017
·
Marine Dutertre
, Lise Cuzin
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
46
Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort
2020
·
Isabelle Poizot-Martin
, Caroline Lions
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
38
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
2017
·
the Dat’AIDS Study Group
, Victor Virlogeux
, et al.
·
BMC Medicine
·
38
PDF
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
2022
·
Luis M. Molinos-Albert
, Valérie Lorin
, et al.
·
Nature Communications
·
33
PDF
Clinical and virological features of acute hepatitis A during an ongoing outbreak among men who have sex with men in the North of France
2018
·
Anne Boucher
, Agnes Meybeck
, et al.
·
Sexually Transmitted Infections
·
32
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
2019
·
Pierre Gantner
, Laurent Cotte
, et al.
·
PLoS ONE
·
29
PDF
High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort
2022
·
Thomas Lemmet
, Laurent Cotte
, et al.
·
PLoS ONE
·
27
PDF
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – “En route for eradication”?
2017
·
Pierre Pradat
, Pascal Pugliese
, et al.
·
Journal of Infection
·
26
Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay
2019
·
Enagnon Kazali Alidjinou
, Pauline Coulon
, et al.
·
Journal of Clinical Virology
·
23
PDF
Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015
2019
·
Isabelle Poizot-Martin
, Caroline Lions
, et al.
·
AIDS
·
22
In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control
2023
·
Pauline Trémeaux
, Frédéric Lemoine
, et al.
·
Microbiology Spectrum
·
20
PDF
Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients
2020
·
Agnès Meybeck
, Enagnon Kazali Alidjinou
, et al.
·
AIDS Patient Care and STDs
·
19
PDF
Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018
2021
·
Laurent Cotte
, Laurent Hocqueloux
, et al.
·
Clinical Infectious Diseases
·
17
Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
2016
·
Paul de Boissieu
, Moustapha Dramé
, et al.
·
Medicine
·
13
Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping
2021
·
Laurine Millière
, Laurence Bocket
, et al.
·
Journal of Antimicrobial Chemotherapy
·
12
HIV pre-exposure prophylaxis (PrEP) knowledge among general practitioners in 2020: A French survey
2023
·
May Gilles
, Macha Tetart
, et al.
·
Infectious Diseases Now
·
11
Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study
2017
·
Lise Cuzin
, Pascal Pugliese
, et al.
·
PLoS ONE
·
11
PDF
Routine drug resistance testing in proviral HIV‐1 DNA: Prevalence of stop codons and hypermutation, and associated factors
2019
·
Enagnon Kazali Alidjinou
, Joséphine Deldalle
, et al.
·
Journal of Medical Virology
·
7
Impact of the COVID-19 pandemic on sexual behaviour and welfare of HIV preexposure prophylaxis users: a mixed-method study
2023
·
Audrey Kamadjou
, Anna Decock
, et al.
·
AIDS Care
·
6
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance
2023
·
Sidonie Lambert-Niclot
, Basma Abdi
, et al.
·
Journal of Antimicrobial Chemotherapy
·
5
Show more works
View as search
Works count:
44
Citation count:
849
H-index:
17
I10-index:
22
Year
Topic
Type